April C. Pettit, MD, MPH

 

 

Academic Rank:

Assistant Professor

Title:

Physician Scientist

Joined Vanderbilt:

2009

 

Practice Address

Vanderbilt Health One Hundred Oaks

Vanderbilt Comprehensive Care Clinic

719 Thompson Lane, Suite 37189

Nashville, TN 37204

Phone: (615) 875-5111

Fax: (615) 875-5115

http://www.vanderbilthealth.com/comprehensivecare/

 

Office Address

1161 21st Avenue South

Nashville, TN 37232-2582

Phone: (615) 322-2035

Fax: (615) 343-6160

Webpage: https://medicine.mc.vanderbilt.edu/id

 

Education & Training

Undergraduate

University of Michigan-Ann Arbor MI, 1996 - 2000

Medical School

Wayne State University School of Medicine-Detroit MI, 2000 - 2004

Graduate

Masters of Public Health, Thesis: “Recurrent Tuberculosis in Tennessee,” Vanderbilt University School of Medicine, Nashville, TN, 2008- 2010

Residency

Vanderbilt University School of Medicine-Nashville TN, 2004 – 2007

Fellowship

Vanderbilt University School of Medicine-Nashville TN, 2007 – 2009

Research Fellowship

Vanderbilt University School of Medicine-Nashville TN, Research Fellow-Infectious Diseases, Mentor: Timothy Sterling, MD, 2009 - 2011

 

Vanderbilt University School of Medicine-Nashville TN,Chief Fellow-Infectious Diseases, 2009 – 2011

 

A.G. Holley State TB Hospital-Lantana FL, Mini-Fellow, 1/2010

                                               

Honors/Awards

Undergraduate Class Honors, University of Michigan, Ann Arbor, MI, March 2000                        

Medical School Year III Honors, Wayne State University School of Medicine, Detroit, MI, November 2003        

Alpha Omega Alpha, Wayne State University School of Medicine, Detroit, MI, March 2004                           

Fellows Scholarship Program to attend the 47th Annual ICAAC, Pfizer, Inc., September 2007

Master in Public Health Tuition Scholarship, Vanderbilt University School of Medicine, Nashville, TN, July 2008        

Travel Grant Award, American Thoracic Society Conference, ATS Assembly on Microbiology, Tuberculosis, and Pulmonary Infections, May 2009    

National Institutes of Health Clinical Loan Repayment Program, National Institute of Allergy and Infectious Diseases, August 2009-August 2011

Young Investigator Award, 17th Annual Conference on Retroviruses and Opportunistic Infections, November 2009   

Infectious Diseases Outstanding Fellow, Vanderbilt University School of Medicine, June 2011

National Institutes of Health Clinical Loan Repayment Program, One Year Renewal, National Institute of Allergy and Infectious Diseases, August 2012-August 2013

Tennessean of the Year 2012, The Tennessean Editorial Board, December 2012

Best Physicians of the Year 2012, Medscape, January 2013

2013 Tennessee Hospital Association Meritorious Service Award, September 2013

National Institutes of Health Clinical Loan Repayment Program, Two Year Renewal, National Institute of Allergy and Infectious Diseases, August 2014-August 2016

 

 

Selected Publications

Pettit A, Barkanic G, Blackwell R, Raffanti SP, Shepherd BE, Sterling TR.  Preventable Tuberculosis Among HIV-infected Persons in the Era of Highly Active Antiretroviral Therapy.  International Journal of Tuberculosis and Lung Disease 2009; (13)3:1-5. PMCID:2866056

Pettit A, Bradford R, Wright P, Mulligan M, Moreland L, McLain D, Gnann J, Bloch K.  Herpes Simplex Encephalitis During Treatment with Tumor Necrosis Alpha Inhibitors.  Clinical Infectious Diseases 2009; 49 (6): 924-7.

Pettit AC, Kaltenbach LA, Maruri F, Cummins J, Smith TR, Warkentin JV, Griffin MR, Sterling, TR.  Chronic Lung Disease and HIV Infection are Risk Factors for Recurrent Tuberculosis in a Low Incidence Setting.  International Journal of Tuberculosis and Lung Disease 2011; 15(7): 906-911. PMCID:3172045

Pettit AC, Jenkins CA, Stinnette SE, Rebeiro PF, Blackwell RB, Raffanti SP, Shepherd BE, Sterling TR.  Tuberculosis Risk Before and After Highly Active Antiretroviral Therapy Initiation:  Does HAART Increase the Short-term TB Risk in a Low Incidence TB Setting?  Journal of Acquired Immune Deficiency Syndromes  2011; 57(4): 305-310. PMCID:3172045

Pettit AC, Jahangir A, Wright P.  Mycobacterium doricum Osteomyelitis and Soft Tissue Infection Following Trauma.  Emerging Infectious Diseases 2011; 17(11): 2075-7. PMCID:3310567

Pettit AC, Kropski JA, Castilho JL, Schmitz JE, Rauch CA, Mobley BC, Wang XJ, Spires SS, Pugh ME. The Index Case for the Fungal Meningitis Outbreak in the United States. New England Journal of Medicine 2012; 367(22): 2219-25.

Pettit AC, Cummins J, Kaltenbach LA, Sterling TR, Warkentin JV.  Non-adherence and Drug-related Interruptions are Risk Factors for Delays in Tuberculosis Treatment Completion.  International Journal of Tuberculosis and Lung Disease 2013; 17(4): 486-92.

Pettit AC, Bethel J, Hirsch-Moverman Y, Colson PW, Sterling TR for the Tuberculosis Epidemiologic Studies Consortium (TBESC).  Female Sex and Discontinuation of Isoniazid due to Adverse Effects During the Treatment of Latent TB.  Journal of Infection 2013; 67 (5): 424-32.

Person AK, Pettit AC, Sterling TR.  Diagnosis and treatment of latent tuberculosis infection: an update.  Current Respiratory Care Reports 2013; DOI 10.1007/s13665-013-0064-y.

Pettit AC, Raynor MB, Schwartz HS, Wright PW.  Histoplasmosis Masquerading as a Rheumatoid Nodule in an Immunocompromised Host: a case report.  Journal of Bone and Joint Surgery: Case Connector (in press).

Pettit AC, Malani A.  Outbreak of Fungal Infections Associated with Contaminated Methylprednisolone Acetate:  An Update.  Current Infectious Disease Reports (in press).

 

 

Research/Clinical Interests 

My clinical and research interests include the epidemiology of and outcomes for patients with tuberculosis, HIV-infection, and TB/HIV co-infection.  I have worked with local sources of data including the Vanderbilt Comprehensive Care Center (VCCC) and the Tennessee TB registry as well as international sources of data such as the North American AIDS Collaboration on Research and Design (NA-ACCORD) and the International epidemiologic Databases to Evaluate AIDS (IeDEA).  I am also involved in clinical research via two consortia sponsored by the Centers for Disease Control and Prevention including the TB Epidemiologic Studies Consortium (TBESC) and TB Trials Consortium (TBTC).